3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine

C76H93N33O6 — CID 157404055

IUPAC3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine
SMILESCCN(CC)c1ccc(Nc2nc(N)n(-c3ccnc(N4CCCCC4)n3)n2)cc1.COc1ccc(Nc2nc(N)n(-c3ccnc(N4CCCCC4)n3)n2)cc1OC.Nc1nc(Nc2ccc3c(c2)OCO3)nn1-c1ccnc(N2CCCCC2)n1.Nc1nc(Nc2ccc3c(c2)OCO3)nn1-c1nccc(N2CCCCC2)n1
InChIInChI=1S/C21H29N9.C19H24N8O2.2C18H20N8O2/c1-3-28(4-2)17-10-8-16(9-11-17)24-20-26-19(22)30(27-20)18-12-13-23-21(25-18)29-14-6-5-7-15-29;1-28-14-7-6-13(12-15(14)29-2)22-18-24-17(20)27(25-18)16-8-9-21-19(23-16)26-10-4-3-5-11-26;19-16-23-17(21-12-4-5-13-14(10-12)28-11-27-13)24-26(16)15-6-7-20-18(22-15)25-8-2-1-3-9-25;19-16-23-17(21-12-4-5-13-14(10-12)28-11-27-13)24-26(16)18-20-7-6-15(22-18)25-8-2-1-3-9-25/h8-13H,3-7,14-15H2,1-2H3,(H3,22,24,26,27);6-9,12H,3-5,10-11H2,1-2H3,(H3,20,22,24,25);2*4-7,10H,1-3,8-9,11H2,(H3,19,21,23,24)
InChIKeyBNMVMXZCRMDTHH-UHFFFAOYSA-N
MW1564.80 g/mol
LogP9.81
Rot. Bonds21

About 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine

3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine (PubChem CID 157404055) has the molecular formula C76H93N33O6 and a molecular weight of 1564.80 g/mol. Its IUPAC name is 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine.

Molecular Properties

Compound Name3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine
PubChem CID157404055
Molecular FormulaC76H93N33O6
Molecular Weight1564.80 g/mol
Exact Mass1563.80
IUPAC Name3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine
SMILESCCN(CC)c1ccc(Nc2nc(N)n(-c3ccnc(N4CCCCC4)n3)n2)cc1.COc1ccc(Nc2nc(N)n(-c3ccnc(N4CCCCC4)n3)n2)cc1OC.Nc1nc(Nc2ccc3c(c2)OCO3)nn1-c1ccnc(N2CCCCC2)n1.Nc1nc(Nc2ccc3c(c2)OCO3)nn1-c1nccc(N2CCCCC2)n1
InChIInChI=1S/C21H29N9.C19H24N8O2.2C18H20N8O2/c1-3-28(4-2)17-10-8-16(9-11-17)24-20-26-19(22)30(27-20)18-12-13-23-21(25-18)29-14-6-5-7-15-29;1-28-14-7-6-13(12-15(14)29-2)22-18-24-17(20)27(25-18)16-8-9-21-19(23-16)26-10-4-3-5-11-26;19-16-23-17(21-12-4-5-13-14(10-12)28-11-27-13)24-26(16)15-6-7-20-18(22-15)25-8-2-1-3-9-25;19-16-23-17(21-12-4-5-13-14(10-12)28-11-27-13)24-26(16)18-20-7-6-15(22-18)25-8-2-1-3-9-25/h8-13H,3-7,14-15H2,1-2H3,(H3,22,24,26,27);6-9,12H,3-5,10-11H2,1-2H3,(H3,20,22,24,25);2*4-7,10H,1-3,8-9,11H2,(H3,19,21,23,24)
InChIKeyBNMVMXZCRMDTHH-UHFFFAOYSA-N
XLogP9.81
TPSA449.74 Ų
H-Bond Donors8
H-Bond Acceptors39
Rotatable Bonds21
Heavy Atoms115
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001564.80
LogP ≤ 59.81
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine?
The IUPAC name of 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine (CID 157404055) is 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine.
What is the SMILES notation for 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine?
The canonical SMILES for 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine is CCN(CC)c1ccc(Nc2nc(N)n(-c3ccnc(N4CCCCC4)n3)n2)cc1.COc1ccc(Nc2nc(N)n(-c3ccnc(N4CCCCC4)n3)n2)cc1OC.Nc1nc(Nc2ccc3c(c2)OCO3)nn1-c1ccnc(N2CCCCC2)n1.Nc1nc(Nc2ccc3c(c2)OCO3)nn1-c1nccc(N2CCCCC2)n1.
What is the InChIKey of 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine?
The InChIKey is BNMVMXZCRMDTHH-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H29N9.C19H24N8O2.2C18H20N8O2/c1-3-28(4-2)17-10-8-16(9-11-17)24-20-26-19(22)30(27-20)18-12-13-23-21(25-18)29-14-6-5-7-15-29;1-28-14-7-6-13(12-15(14)29-2)22-18-24-17(20)27(25-18)16-8-9-21-19(23-16)26-10-4-3-5-11-26;19-16-23-17(21-12-4-5-13-14(10-12)28-11-27-13)24-26(16)15-6-7-20-18(22-15)25-8-2-1-3-9-25;19-16-23-17(21-12-4-5-13-14(10-12)28-11-27-13)24-26(16)18-20-7-6-15(22-18)25-8-2-1-3-9-25/h8-13H,3-7,14-15H2,1-2H3,(H3,22,24,26,27);6-9,12H,3-5,10-11H2,1-2H3,(H3,20,22,24,25);2*4-7,10H,1-3,8-9,11H2,(H3,19,21,23,24).
What are the key properties of 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine?
3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine has a molecular weight of 1564.80 g/mol, XLogP of 9.81, 21 rotatable bonds, 8 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 3-N-(1,3-benzodioxol-5-yl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(1,3-benzodioxol-5-yl)-1-(4-piperidin-1-ylpyrimidin-2-yl)-1,2,4-triazole-3,5-diamine;3-N-[4-(diethylamino)phenyl]-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine;3-N-(3,4-dimethoxyphenyl)-1-(2-piperidin-1-ylpyrimidin-4-yl)-1,2,4-triazole-3,5-diamine is sourced from PubChem (CID 157404055), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).